Wolfgang Willenbacher
AuthID: R-00F-GEY
1
TÃTULO: Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply
AUTORES: David H Henry; Luis Costa; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 19
AUTORES: David H Henry; Luis Costa; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 19
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
AUTORES: David H Henry; Luis Costa ; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Penella J Woll; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 9
AUTORES: David H Henry; Luis Costa ; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Penella J Woll; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 9
INDEXADO EM: WOS 
CrossRef
WOS CrossRef